{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:36:25Z","timestamp":1790847385303,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T00:00:00Z","timestamp":1459382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s11926-016-0576-x","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T09:01:20Z","timestamp":1459414880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Pediatric Mixed Connective Tissue Disease"],"prefix":"10.1007","volume":"18","author":[{"given":"Roberta A.","family":"Berard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald M.","family":"Laxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"key":"576_CR1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","volume":"52","author":"GC Sharp","year":"1972","unstructured":"Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease\u2014an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52:148\u201359.","journal-title":"Am J Med"},{"key":"576_CR2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(77)80555-6","volume":"90","author":"BH Singsen","year":"1977","unstructured":"Singsen BH et al. Mixed connective tissue disease in childhood. A clinical and serologic survey. J Pediatr. 1977;90:893\u2013900.","journal-title":"J Pediatr"},{"key":"576_CR3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/archpedi.1978.02120280047010","volume":"132","author":"A Fraga","year":"1978","unstructured":"Fraga A, Gudino J, Ramos-Niembro F, Aiarcon-Segovia D. Mixed connective tissue disease in childhood. Relationship Sjogren\u2019s syndrome. Am J Dis Child. 1978;132:263\u20135.","journal-title":"Am J Dis Child"},{"key":"576_CR4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.rdc.2005.04.007","volume":"31","author":"M Aringer","year":"2005","unstructured":"Aringer M, Steiner G, Smolen JS. Does mixed connective tissue disease exist? Yes. Rheum Dis Clin North Am. 2005;31:411\u201320.","journal-title":"Rheum Dis Clin North Am"},{"key":"576_CR5","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1529-0131(199805)41:5<768::AID-ART3>3.0.CO;2-Z","volume":"41","author":"JS Smolen","year":"1998","unstructured":"Smolen JS, Steiner G. Mixed connective tissue disease: to be or not to be? Arthritis Rheum. 1998;41:768\u201377.","journal-title":"Arthritis Rheum"},{"key":"576_CR6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/1529-0131(199905)42:5<899::AID-ANR8>3.0.CO;2-L","volume":"42","author":"MA Burdt","year":"1999","unstructured":"Burdt MA et al. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum. 1999;42:899\u2013909.","journal-title":"Arthritis Rheum"},{"key":"576_CR7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00005792-198007000-00001","volume":"59","author":"SH Nimelstein","year":"1980","unstructured":"Nimelstein SH, Brody S, McShane D, Holman HR. Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine (Baltimore). 1980;59:239\u201348.","journal-title":"Medicine (Baltimore)"},{"key":"576_CR8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/art.1780380216","volume":"38","author":"NS Gendi","year":"1995","unstructured":"Gendi NS et al. HLA type as a predictor of mixed connective tissue disease differentiation. Ten-year clinical and immunogenetic follow up of 46 patients. Arthritis Rheum. 1995;38:259\u201366.","journal-title":"Arthritis Rheum"},{"key":"576_CR9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.rdc.2005.04.009","volume":"31","author":"J Swanton","year":"2005","unstructured":"Swanton J, Isenberg D. Mixed connective tissue disease: still crazy after all these years. Rheum Dis Clin North Am. 2005;31:421\u201336.","journal-title":"Rheum Dis Clin North Am"},{"key":"576_CR10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/rheumatology\/31.10.695","volume":"31","author":"C Black","year":"1992","unstructured":"Black C, Isenberg DA. Mixed connective tissue disease\u2014goodbye to all that. Br J Rheumatol. 1992;31:695\u2013700.","journal-title":"Br J Rheumatol"},{"key":"576_CR11","first-page":"545","volume-title":"Les Maladies Systemiques","author":"MF Kahn","year":"1991","unstructured":"Kahn MF, Appelboom T. In: Kahn MF, Peltier AP, Meyer O, editors. Les Maladies Systemiques. Paris: Flammarion; 1991. p. 545\u201356."},{"key":"576_CR12","first-page":"23","volume-title":"Mixed connective tissue diseases and anti-nuclear antibodies","author":"GC Sharp","year":"1987","unstructured":"Sharp GC. In: Kasukawa R, Sharp GC, editors. Mixed connective tissue diseases and anti-nuclear antibodies. Amsterdam: Excerpta Medica; 1987. p. 23\u201332."},{"key":"576_CR13","first-page":"41","volume-title":"Mixed connective tissue disease and anti-nuclear anti-bodies","author":"R Kasukawa","year":"1987","unstructured":"Kasukawa R. In: Kasukawa R, Sharp GC, editors. Mixed connective tissue disease and anti-nuclear anti-bodies. Amsterdam: Exerpta Medica; 1987. p. 41\u20138."},{"key":"576_CR14","first-page":"33","volume-title":"Mixed connective tissue disease and anti-nuclear anti-bodies","author":"D Alarcon-Segovia","year":"1987","unstructured":"Alarcon-Segovia D, Villarreal M. In: Kasukawa R, Sharp GC, editors. Mixed connective tissue disease and anti-nuclear anti-bodies. Amsterdam: Excerpta Medica; 1987. p. 33\u201340."},{"key":"576_CR15","first-page":"2055","volume":"23","author":"JM Amigues","year":"1996","unstructured":"Amigues JM, Cantagrel A, Abbal M, Mazieres B. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J Rheumatol. 1996;23:2055\u201362.","journal-title":"J Rheumatol"},{"key":"576_CR16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.semarthrit.2011.07.010","volume":"41","author":"S Cappelli","year":"2012","unstructured":"Cappelli S et al. \u201cTo be or not to be,\u201d ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum. 2012;41:589\u201398.","journal-title":"Semin Arthritis Rheum"},{"key":"576_CR17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0961203309345782","volume":"19","author":"LV Lage","year":"2010","unstructured":"Lage LV, Caleiro MT, Carvalho JF. Proposed disease activity criteria for mixed connective tissue disease. Lupus. 2010;19:223\u20134.","journal-title":"Lupus"},{"key":"576_CR18","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/rheumatology\/keu310","volume":"54","author":"ST Flam","year":"2015","unstructured":"Flam ST et al. The HLA profiles of mixed connective tissue disease differ distinctly from the profiles of clinically related connective tissue diseases. Rheumatology (Oxford). 2015;54:528\u201335.","journal-title":"Rheumatology (Oxford)"},{"key":"576_CR19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clim.2008.03.461","volume":"128","author":"RW Hoffman","year":"2008","unstructured":"Hoffman RW, Maldonado ME. Immune pathogenesis of mixed connective tissue disease: a short analytical review. Clin Immunol. 2008;128:8\u201317.","journal-title":"Clin Immunol"},{"key":"576_CR20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/08916930701262986","volume":"40","author":"MP Keith","year":"2007","unstructured":"Keith MP et al. Anti-ribonucleoprotein antibodies mediate enhanced lung injury following mesenteric ischemia\/reperfusion in Rag-1(\u2212\/\u2212) mice. Autoimmunity. 2007;40:208\u201316.","journal-title":"Autoimmunity"},{"key":"576_CR21","first-page":"409","volume":"22","author":"E Bodolay","year":"2004","unstructured":"Bodolay E et al. Anti-endothelial cell antibodies in mixed connective tissue disease: frequency and association with clinical symptoms. Clin Exp Rheumatol. 2004;22:409\u201315.","journal-title":"Clin Exp Rheumatol"},{"key":"576_CR22","volume-title":"Textbook of pediatric rheumatology","author":"R Petty","year":"2016","unstructured":"Petty R, Laxer R, Lindsey C, Wedderburn L. Textbook of pediatric rheumatology. Philadelphia: Elsevier; 2016."},{"key":"576_CR23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/kev300","volume":"55","author":"R Gunnarsson","year":"2016","unstructured":"Gunnarsson R et al. Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease. Rheumatology (Oxford). 2016;55:103\u20138. This study examines the serologic risk factors for ILD in MCTD and the authors identified the presence of anti-Ro52 as a potential risk factor for pulmonary fibrosis.","journal-title":"Rheumatology (Oxford)"},{"key":"576_CR24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/03009741003742714","volume":"39","author":"J Net van der","year":"2010","unstructured":"van der Net J, Wissink B, van Royen A, Helders PJ, Takken T. Aerobic capacity and muscle strength in juvenile-onset mixed connective tissue disease (MCTD). Scand J Rheumatol. 2010;39:387\u201392.","journal-title":"Scand J Rheumatol"},{"key":"576_CR25","first-page":"1088","volume":"23","author":"L Kotajima","year":"1996","unstructured":"Kotajima L et al. Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nationwide collaborative study in Japan. J Rheumatol. 1996;23:1088\u201394.","journal-title":"J Rheumatol"},{"key":"576_CR26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.rdc.2005.04.002","volume":"31","author":"RJ Mier","year":"2005","unstructured":"Mier RJ et al. Pediatric-onset mixed connective tissue disease. Rheum Dis Clin North Am. 2005;31:483\u201396. vii.","journal-title":"Rheum Dis Clin North Am"},{"key":"576_CR27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12969-015-0046-4","volume":"13","author":"K Sedej","year":"2015","unstructured":"Sedej K et al. Autoimmune hepatitis as a presenting manifestation of mixed connective tissue disease in a child. Case report and review of the literature. Pediatr Rheumatol Online J. 2015;13:47.","journal-title":"Pediatr Rheumatol Online J"},{"key":"576_CR28","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.3899\/jrheum.081314","volume":"36","author":"A Hajas","year":"2009","unstructured":"Hajas A et al. Sensorineural hearing loss in patients with mixed connective tissue disease: immunological markers and cytokine levels. J Rheumatol. 2009;36:1930\u20136.","journal-title":"J Rheumatol"},{"key":"576_CR29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/02841850902787677","volume":"50","author":"TM Aalokken","year":"2009","unstructured":"Aalokken TM et al. Chest abnormalities in juvenile-onset mixed connective tissue disease: assessment with high-resolution computed tomography and pulmonary function tests. Acta Radiol. 2009;50:430\u20136.","journal-title":"Acta Radiol"},{"key":"576_CR30","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/rheumatology\/keh575","volume":"44","author":"E Bodolay","year":"2005","unstructured":"Bodolay E et al. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology (Oxford). 2005;44:656\u201361.","journal-title":"Rheumatology (Oxford)"},{"key":"576_CR31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00005792-198403000-00003","volume":"63","author":"WD Sullivan","year":"1984","unstructured":"Sullivan WD et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore). 1984;63:92\u2013107.","journal-title":"Medicine (Baltimore)"},{"key":"576_CR32","unstructured":"Hetlevik, S., Flato, B., Rygg, M., Nordal, E. & Lilleby, V. Disease activity, disease damage and predictive factors in juvenile onset mixed connective tissue disease\u2014a Norwegian nationwide study. Arthritis Rheum 67 (2015)."},{"key":"576_CR33","doi-asserted-by":"crossref","first-page":"R302","DOI":"10.1186\/ar1490","volume":"7","author":"D Hof","year":"2005","unstructured":"Hof D et al. Autoantibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease. Arthritis Res Ther. 2005;7:R302\u20139. This recent study presents new outcome data for 48 patients with MCTD. The study presents the first data of potential predictors of damage and active disease in pediatric MCTD.","journal-title":"Arthritis Res Ther"},{"key":"576_CR34","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1177\/0961203312456751","volume":"21","author":"P Szodoray","year":"2012","unstructured":"Szodoray P et al. Distinct phenotypes in mixed connective tissue disease: subgroups and survival. Lupus. 2012;21:1412\u201322.","journal-title":"Lupus"},{"key":"576_CR35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-3476(06)80112-5","volume":"122","author":"HA Tiddens","year":"1993","unstructured":"Tiddens HA et al. Juvenile-onset mixed connective tissue disease: longitudinal follow-up. J Pediatr. 1993;122:191\u20137.","journal-title":"J Pediatr"},{"key":"576_CR36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.23303","volume":"58","author":"X Jais","year":"2008","unstructured":"Jais X et al. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum. 2008;58:521\u201331.","journal-title":"Arthritis Rheum"},{"key":"576_CR37","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","volume":"346","author":"LJ Rubin","year":"2002","unstructured":"Rubin LJ et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med. 2002;346:896\u2013903.","journal-title":"N Engl J Med"},{"key":"576_CR38","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/0961203313485489","volume":"22","author":"B Jovancevic","year":"2013","unstructured":"Jovancevic B, Lindholm C, Pullerits R. Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature. Lupus. 2013;22:664\u201374.","journal-title":"Lupus"},{"key":"576_CR39","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/07853899708999362","volume":"29","author":"H Michels","year":"1997","unstructured":"Michels H. Course of mixed connective tissue disease in children. Ann Med. 1997;29:359\u201364.","journal-title":"Ann Med"},{"key":"576_CR40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10067-009-1276-y","volume":"29","author":"YY Tsai","year":"2010","unstructured":"Tsai YY et al. Fifteen-year experience of pediatric-onset mixed connective tissue disease. Clin Rheumatol. 2010;29:53\u20138.","journal-title":"Clin Rheumatol"},{"key":"576_CR41","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/acr.20497","volume":"63","author":"CA Wallace","year":"2011","unstructured":"Wallace CA et al. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2011;63:929\u201336.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"576_CR42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1546-0096-12-42","volume":"12","author":"A Knight","year":"2014","unstructured":"Knight A et al. Depression and anxiety and their association with healthcare utilization in pediatric lupus and mixed connective tissue disease patients: a cross-sectional study. Pediatr Rheumatol Online J. 2014;12:42.","journal-title":"Pediatr Rheumatol Online J"},{"key":"576_CR43","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jpeds.2015.07.048","volume":"167","author":"A Knight","year":"2015","unstructured":"Knight A et al. Identifying differences in risk factors for depression and anxiety in pediatric chronic disease: a matched cross-sectional study of youth with lupus\/mixed connective tissue disease and their peers with diabetes. J Pediatr. 2015;167:1397\u20131403 e1.","journal-title":"J Pediatr"},{"key":"576_CR44","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar2999","volume":"12","author":"P Soltesz","year":"2010","unstructured":"Soltesz P et al. Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease. Arthritis Res Ther. 2010;12:R78. This study highlights the prevalence and risk factors for mood disorders in MCTD as well as the lower rates of visits for mental health care.","journal-title":"Arthritis Res Ther"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-016-0576-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-016-0576-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-016-0576-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:50:12Z","timestamp":1559436612000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-016-0576-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["576"],"URL":"https:\/\/doi.org\/10.1007\/s11926-016-0576-x","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]},"article-number":"28"}}